Andere Sprachen AlzChem Group AG

Aktien

A2YNT3

DE000A2YNT30

ACT

Markt geschlossen - Xetra Andere Börsenplätze 17:36:08 29.04.2024			Nachbörslich 20:32:45
45,3 ^EUR	-1,09 %		45,5	+0,44 %

15.03.	Deutsche Rüstungsindustrie bekommt für Projekte EU-Millionen	DP
01.03.	Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Young researchers in action: Chemistry Olympiad as a guest at Alzchem	25.04.
AlzChem : Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212	22.03.
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding	15.03.
Deutsche Rüstungsindustrie bekommt für Projekte EU-Millionen	15.03.
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments	11.03.
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success	01.03.
AlzChem Group AG Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01.03.
AlzChem Group AG Reports Earnings Results for the Full Year Ended December 31, 2023	01.03.
AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	21.02.
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation	11.01.
AlzChem : Happy New Year 2024	02.01.
Alzchem Group AG awarded for sustainable supply chains: Outstanding result certified by 'Together for Sustainability (TfS)' initiative	13.12.
Germany’s Alzchem Group Names New CFO	08.12.
Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024	08.12.
Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024	08.12.
AlzChem Group AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27.10.23
Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in the nine-month period 2023	26.10.23
Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation	18.10.23
Alzchem Group AG: Creatine product 'Creavitalis': Wholesome taste and positive benefits for vegetarian and vegan foods	14.09.23
AlzChem Group AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AlzChem Group AG

Aktien

A2YNT3

DE000A2YNT30

ACT

Andere Sprachen

Filter